Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
boston
7
×
boston blog main
deals
7
×
fda
7
×
investing
7
×
life sciences
national blog main
boston top stories
clinical trials
san francisco blog main
startups
medical device
national top stories
clinical trial
drug delivery
eli lilly
medical devices
medtronic
new york blog main
perceptive advisors
roche
san diego blog main
san francisco top stories
venture capital
480 biomedical
abbott laboratories
adel malek
akouos
arrowmark partners
arsenal medical
astellas pharmaceuticals
aton partners
atrial fibrillation
avapritinib
beta bionics
bigfoot biomedical
biofourmis
biovotion
blueprint medicines
What
developing
device
million
startup
therapeutics
treat
drug
fda
ipo
medical
medicines
new
patients
raised
tests
absorb
acquire
adding
address
affects
americans
analytics
approval
approved
atrial
beta
biofourmis
bionics
biotech
blood
blueprint
body
boston
brain
builds
business
called
cancer
candidate
cerevasc
Language
unset
Current search:
biotech
×
deals
×
investing
×
fda
×
boston
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
3 years ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion